The debate on National Drugs Policy Bill got underway in Parliament today (04) by President Maithripala Sirisena.
President addressing parliament said even though he also attempted bring this policy as the then Health Minister he did not succeed. Presenting this to parliament during 100-day programme is satisfactory, he further said.
The Minister of Health and Indigenous Medicine Dr. Rajitha Senaratne tabled the National Medicine Regulatory Authority Bill that will implement the National Medicinal Drugs and Devices Policy based on Prof. Senaka Bibile's Essential Medicines Concept.
The Bill will provide for the establishment of a regulatory authority to be known as the National Medicines Regulatory Authority.
The Authority will be responsible for the regulation and control of, Registration, Licensing, Manufacture, Importation and all other aspects pertaining to medicines, medical devices and borderline products.
The National Medicines Regulatory Authority will also be responsible for conducting of clinical trials in a manner compatible with the National Medicines Policy.
Ensuring the availability of safe, efficacious and good quality medicinal drugs, safe, effective and acceptable quality devices and safe and acceptable quality cosmetics to the general public at affordable prices; ensuring that all activities related to importation and registration of medicinal drugs, devices, cosmetics or investigational medicinal products are carried out in a transparent, sustainable and equitable manner; ensure through the services provided by National Medicinal Drug Quality Assurance Laboratory and other recognized laboratories, only efficacious, safe and good quality medicinal drugs are made available 3 to the health care sector and the general public are among the objectives of the policy.